Curcumin Supplementation and Patients With Type 2 Diabetes
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02529982 |
Recruitment Status :
Completed
First Posted : August 20, 2015
Last Update Posted : February 26, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Non Insulin Dependent Diabetes | Dietary Supplement: Curcumin Dietary Supplement: Placebo | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 44 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Investigator) |
Primary Purpose: | Treatment |
Official Title: | The Effect of Curcumin Supplementation on Anthropometric Indices, Insulin Resistance and Oxidative Stress in Patients With Type 2 Diabetes |
Actual Study Start Date : | July 2015 |
Actual Primary Completion Date : | January 2016 |
Actual Study Completion Date : | April 2016 |

Arm | Intervention/treatment |
---|---|
Active Comparator: intervention
500 mg curcumin capsule
|
Dietary Supplement: Curcumin |
Placebo Comparator: control
placebo
|
Dietary Supplement: Placebo |
- fasting blood sugar [ Time Frame: 10 weeks ]
- Insulin [ Time Frame: 10 week ]
- HbA1c [ Time Frame: 10 week ]
- Homeostatic Model Assessment of Insulin Resistance [ Time Frame: 10 week ]
- Change in pancreatic B-cell function [ Time Frame: 10 week ]
- total capacity antioxidant [ Time Frame: 10 weeks ]
- Malondialdehyde [ Time Frame: 10 week ]
- Body mass index [ Time Frame: 10 week ]
- Waist circumference [ Time Frame: 10 week ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 40 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
insulin Inclusion Criteria:
- a) Tendency to participate b) Age range of 40-65 c) Suffering from diabetes type 2 ( between 1 to 10 yeares) d) BMI 18/5-30 e) Patients with diabetes who administer oral hypoglycemic agents and do not use
Exclusion Criteria:
- a) patients with liver diseases b) patients with kidney diseases c) patients with inflammatory diseases d) patients with liver diseases e) Administering herbal agents f) Administering multivitamins and minerals in past 3 months

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02529982
Iran, Islamic Republic of | |
NNFTRI clinic | |
Tehran, Iran, Islamic Republic of, 19435 |
Responsible Party: | Dr Azita Hekmatdoost, Principal Investigator, National Nutrition and Food Technology Institute |
ClinicalTrials.gov Identifier: | NCT02529982 |
Other Study ID Numbers: |
1370 |
First Posted: | August 20, 2015 Key Record Dates |
Last Update Posted: | February 26, 2019 |
Last Verified: | February 2019 |
Diabetes Mellitus Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Curcumin Anti-Inflammatory Agents, Non-Steroidal Analgesics, Non-Narcotic Analgesics |
Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anti-Inflammatory Agents Antirheumatic Agents Antineoplastic Agents Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action |